PRL signaling through multiple pathways has been described for other cell lines, such as PI3K–AKT and STAT in Nb2 rat lymphoma cells [30,31], and STAT5, AKT, and ERK1/2 in T47D breast cancer cells [32]. This evidence concerns the gene MAPK3 and breast carcinoma.